Get Started

EDSA

NASD Edesa Biotech, Inc.
Nov 4, 2026 · 9:55 PM ET EOD Market Closed

$2.17 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.17, $0.21 below the day’s high of $2.38

YTD change
+52.82%
vs 20-day SMA
-23.17%
vs 200-day SMA
-61.71%

Price ranges

Previous day
$2.24 $2.49
open $2.49 close $2.28
-$0.21 (-8.43%)
Today
$2.15 $2.38
open $2.38 now $2.17
-$0.21 (-8.82%)
Past week
$2.24 $2.86
from $2.63 now $2.17
-$0.46 (-17.49%)
Past month
$2.24 $4.01
from $3.72 now $2.17
-$1.55 (-41.67%)
This year
$0.72 $20.32
from $1.42 now $2.17
+$0.75 (+52.82%)

Price & Performance

-13.94 (-86.53%) / 6M

$0.9492$6.85$12.75$18.65May 4Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 98.4% away from all-time highs of $133.70
  • EDSA is up 53% since the beginning of the year
  • EDSA is up 28% over the past 12 months
  • EDSA is down 42% over the past 1 month
  • 1% of all EDSA investors are betting against EDSA

EDSA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +27.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.6
Earnings momentum -2.9% Quarterly EPS growth
Quarterly change -2.9%

Valuation

P/E ratio N/A
Enterprise value $18.6M
Beta 2.24

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$10.3M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $30.8M

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.